CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population-Reference-Cited by-全球学者库

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Published:2019-03 Issue:2 Volume:42 Page:32-36
ISSN:1537-162X
Container-title:Clinical Neuropharmacology
language:en
Short-container-title:Clin Neuropharm

Author:

Zhu Yuhao,Zhang Naixing,Ren Decheng,Bi Yan,Xu Fei,Niu Weibo,Sun Qianqian,Guo Zhenming,Yuan Ruixue,Yuan Fan,Wu Xi,Cao Yanfei,Yang Fengping,Wang Lu,Du Li,Li Weidong,Xu Yifeng,Li Xingwang,Zhu Liping,He Lin,Shi Lei,He Guang,Yu Tao

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Clinical Neurology,Pharmacology

Reference29 articles.

1. Abnormalities in the structural covariance of emotion regulation networks in major depressive disorder;J Psychiatr Res,2017

2. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression[J];New Engl J Med,2006

3. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice;Am J Psychiatry,2006

4. Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response;Pharmacogenomics,2010

5. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response;Am J Med Genet B Neuropsychiatr Genet,2003

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Which can Predict the Outcome of Antidepressants: Metabolic Genes or Pharmacodynamic Genes?;Current Drug Metabolism;2023-07

2. The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy;Genes;2023-05-16

3. Genic-intergenic polymorphisms of CYP1A genes and their clinical impact;Gene;2023-03

4. Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers;International Journal of Neuropsychopharmacology;2023-01-19

5. No Association Between SLC6A4 Gene Polymorphisms With Treatment Remission to Venlafaxine in Han Chinese Depressive Patients;Clinical Neuropharmacology;2021-01-21